All News

Check out the latest products. From an MRI System that improves lesion conspicuity, a biopsy device receives FDA clearance and an App that tracks stent implants.

Peter C. Black, MD, discusses the current state of immune checkpoint inhibition for bladder cancer in this article from Urology Times SUO internship program member William Parker, MD.

Urology Times SUO internship program member Robert M. Turner, II, MD, reports on a recent presentation by J. Stuart Wolf, Jr., MD, about possible pitfalls of renal mass biopsy.

Lower urinary tract symptoms (LUTS) are not just a problem with staying asleep. Difficulty with sleep may actually impact LUTS, say researchers at Baylor College of Medicine in Houston.

Surveillance “should be more commonly used for patients with low-risk prostate cancer,” argues an author of the endorsement.

Physicians at Vanderbilt University Medical Center, Nashville, have opened a dedicated cardio-oncology service, including urology, medical oncology, radiation oncology, and cardiology.

Nurse practitioner Adele M. Caruso, MSN, CRNP, discusses appropriate timing of follow-up and ponders related health insurance coverage and cancer survivorship issues.

A recent a White House Dialogue on Men’s Health brought together experts on men’s health from government, professional sports, nonprofit organizations, and health care, who together raised awareness of the need for increased focus on men’s health.

The Protecting Americans from Tax Hikes Act of 2015 was signed into law on Dec. 18, 2015. The law renews a long list of tax breaks known as “extenders” that have been expiring on an annual basis.

Two urinary biomarkers for detection of prostate cancer have differing utility in African-American men undergoing prostate biopsy.

Urologists have direct experience with drug shortages and their impact on pricing, thanks to the recent shortage of BCG. A sudden hike in the price of a competing generic drug seemed to be no coincidence, Henry Rosevear, MD, writes. He ponders a few similar, troubling cases and some proposed solutions.

Peyronie’s disease (PD) is surgically treated by a minority of urologists, and urologists who subspecialize in andrology perform a disproportionate number of procedures to treat the condition. Those were among the findings of a case-log analysis that was presented at the 2015 AUA annual meeting in New Orleans and subsequently published in Urology (2016; 87:205-9).

The purpose of this article is to provide a clear understanding of the basis for the genetic and epigenetic tools that are increasingly used in medicine, highlight some of these tools currently used in urology, and explain the clinical and medicolegal ramifications of direct-to-consumer tests.

In this article, I will describe some nuances of buy and bill that you should understand in your roles of small business owner and treatment provider, especially as it pertains to Medicare.

New findings from the Johns Hopkins University School of Medicine in Baltimore should be useful to clinicians looking to counsel anxious prostate cancer patients who are undergoing active surveillance.

In this latest installment of "Coding Q&A," Ray Painter, MD, and Mark Painter also discuss compensation plans and answer a question regarding CPT 76942 and 50200.

Most men with anterior urethral strictures are treated without imaging, and 90% are not being offered urethroplasty.

In this column, I will discuss expert witnesses and preparing for trial in a medical malpractice case.

Once considered a primary option for kidney stone treatment, shock wave lithotripsy appears to be losing traction. Many urologists say its outcomes aren’t as reliable as those from ureteroscopy. But others say it remains an option that works well with proper patient selection and technique and offers what ureteroscopy doesn’t: a noninvasive option.

Telemedicine may provide the answer to costly consultations. According to data from a recent study, remote video visits demonstrated equivalent efficiency and satisfaction when compared with traditional office visits for men with surgically treated prostate cancer.

Overactive bladder (OAB) and falls often carry a substantial burden for patients and society as a whole, and new research suggests that treatment of OAB may lower fall risk. Learn more

Results from a recently published set of coordinated trials indicate that raising testosterone concentrations offers moderate benefits in sexual function and some benefit on mood and depressive symptoms.

Urology Times SUO internship program member Katie Murray, DO, reports on a study evaluating the differences in urine cytology and UroVysion FISH testing results among clinically meaningful patient subgroups.

Urology Times SUO internship program member William Parker, MD, discusses a retrospective review of more than 100 patients at Columbia University Medical Center in New York.

Four PCa studies presented at the 2015 AUA annual meeting in New Orleans shed some light, with researchers emphasizing the need to optimize screening and to improve treatment selection in older men.

The VA Choice program wasn’t designed to bring VA patients to community physicians; rather, it was designed to turn community physicians into VA doctors. And that does not work, says Henry Rosevear, MD. Dr. Rosevear shares his experience with the VA Choice program and shares what he sees as its limitations and what needs to change.

A 2016 study of certificate of need laws showed at least 20 states restrict the technology used for MRI, CT, and PET scans. Many states are now weighing proposals to reform the process by which health facility projects are reviewed, writes the AACU's Ross E. Weber.